4.5 Article

CDK9 is up-regulated and associated with prognosis in patients with papillary thyroid carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Predictive Value of Delphian Lymph Node Metastasis in the Thyroid Cancer

Do Hyun Kim et al.

Summary: This study evaluated the diagnostic accuracy of Delphian lymph node (DLN) metastasis for predicting central lymph node (CLN) metastasis and lateral lymph node (LLN) metastasis. The results showed that DLN metastasis had moderate predictive ability for CLN and LLN metastasis and was associated with specific clinicopathological characteristics.

LARYNGOSCOPE (2021)

Article Oncology

Delphian lymph node metastasis is a novel indicator of tumor aggressiveness and poor prognosis in papillary thyroid cancer

Youzhi Zhu et al.

Summary: The study found that DLN metastasis in PTC is associated with tumor aggressiveness and a poor prognosis.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Endocrinology & Metabolism

Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer

Xingchen Li et al.

Summary: The study analyzed 936 patients with PTC and found that DLN metastasis was significantly correlated with various factors, leading to the development of a diagnostic nomogram. The results demonstrate that DLN metastasis is a critical parameter for predicting metastatic disease in the central compartments.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Cell Biology

CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells

Monika Stetkova et al.

CELL DEATH & DISEASE (2020)

Review Cell Biology

Special types of thyroid carcinoma

Zubair W. Baloch et al.

HISTOPATHOLOGY (2018)

Article Biotechnology & Applied Microbiology

MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9

Yebin Lu et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)

Article Oncology

The significance of Delphian lymph node in papillary thyroid cancer

Zhuo Tan et al.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)

Article Oncology

CDK9 is a prognostic marker and therapeutic target in pancreatic cancer

Anna-Laura Kretz et al.

TUMOR BIOLOGY (2017)

Review Cell Biology

Overview of CDK9 as a target in cancer research

Fatima Morales et al.

CELL CYCLE (2016)

Article Medicine, Research & Experimental

RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation

Qi Xie et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)